Research ArticleArticle

Laser Doppler Perfusion Imaging Is Useful in the Study of Raynaud’s Phenomenon and Improves the Capillaroscopic Diagnosis

EDOARDO ROSATO, FEDERICA BORGHESE, SIMONETTA PISARRI and FELICE SALSANO
The Journal of Rheumatology October 2009, 36 (10) 2257-2263; DOI: https://doi.org/10.3899/jrheum.090187

REFERENCES

  1. 1.↵
    1. Wigley FM
    . Clinical practice. Raynaud’s phenomenon. N Engl J Med 2002;347:1001–8.
    OpenUrlCrossRefPubMed
  2. 2.↵
    1. LeRoy EC,
    2. Black C,
    3. Fleischmajer R,
    4. Jablonska S,
    5. Krieg T,
    6. Medsger TA, Jr,
    7. et al.
    Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 1998;15:202–5.
    OpenUrl
  3. 3.↵
    1. Kahaleh MB
    . Vascular involvement in systemic sclerosis (SSc). Clin Exp Rheumatol 2004;22 Suppl:19–23.
    OpenUrl
  4. 4.↵
    1. Herrick AL
    . Pathogenesis of Raynaud’s phenomenon. Rheumatology 2005;44:587–96.
    OpenUrlAbstract/FREE Full Text
  5. 5.↵
    1. Flavahan NA,
    2. Flavahan S,
    3. Mitra S,
    4. Chotani MA
    . The vasculopathy of Raynaud’s phenomenon and scleroderma. Rheum Dis Clin North Am 2003;29:275–91.
    OpenUrlCrossRefPubMed
  6. 6.↵
    1. Salsano F,
    2. Letizia C,
    3. Proietti M,
    4. Rossi C,
    5. Proietti AR,
    6. Rosato E,
    7. et al.
    Significant changes of peripheral perfusion and plasma adrenomedullin levels in acetylcysteine long term treatment of patients with sclerodermic Raynaud’s phenomenon. Int J Immunopathol Pharmacol 2005;18:761–70.
    OpenUrlPubMed
  7. 7.↵
    1. Gayraud M
    . Raynaud’s phenomenon. Joint Bone Spine 2007;74:1–8.
    OpenUrlCrossRefPubMed
  8. 8.↵
    1. Maricq HR,
    2. LeRoy EC
    . Patterns of finger capillary abnormalities in connective tissue disease by ‘wide-field’ microscopy. Arthritis Rheum 1973;16:619–28.
    OpenUrlCrossRefPubMed
  9. 9.↵
    1. Cutolo M,
    2. Sulli A,
    3. Pizzorni C,
    4. Accardo S
    . Nailfold videocapillaroscopy assessment of microvascular damage in systemic sclerosis. J Rheumatol 2000;27:155–60.
    OpenUrlPubMed
  10. 10.↵
    1. Cutolo M,
    2. Sulli A,
    3. Secchi ME,
    4. Paolino S,
    5. Pizzorni C
    . Nailfold capillaroscopy is useful for the diagnosis and follow-up of autoimmune rheumatic diseases. A future tool for the analysis of microvascular heart involvement? Rheumatology 2006;45 Suppl:43–6.
  11. 11.↵
    1. Dabich L,
    2. Bookstein JJ,
    3. Zweifler A,
    4. Zarafonetis CJ
    . Digital arteries in patients with scleroderma. Arteriographic and plethysmographic study. Arch Intern Med 1972;130:708–14.
    OpenUrlCrossRefPubMed
  12. 12.↵
    1. Allanore Y,
    2. Seror R,
    3. Chevrot A,
    4. Kahan A,
    5. Drapé JL
    . Hand vascular involvement assessed by magnetic resonance angiography in systemic sclerosis. Arthritis Rheum 2007;56:2747–54.
    OpenUrlCrossRefPubMed
  13. 13.↵
    1. Merla A,
    2. Di Donato L,
    3. Romani GL,
    4. Proietti M,
    5. Salsano F
    . Comparison of thermal infrared and laser Doppler imaging in the assessment of cutaneous tissue perfusion in scleroderma patients and healthy controls. Int J Immunopathol Pharmacol 2008;21:679–86.
    OpenUrlAbstract/FREE Full Text
  14. 14.↵
    1. Gunawardena H,
    2. Harris ND,
    3. Carmichael C,
    4. McHugh NJ
    . Maximum blood flow and microvascular regulatory responses in systemic sclerosis. Rheumatology 2007;46:1079–82.
    OpenUrlAbstract/FREE Full Text
  15. 15.↵
    1. Terada K,
    2. Miyai N,
    3. Maejima Y,
    4. Sakaguchi S,
    5. Tomura T,
    6. Yoshimasu K,
    7. et al.
    Laser Doppler imaging of skin blood flow for assessing peripheral vascular impairment in hand-arm vibration syndrome. Ind Health 2007;45:309–17.
    OpenUrlCrossRefPubMed
  16. 16.↵
    1. Szabo N,
    2. Csiki Z,
    3. Szanto A,
    4. Danko K,
    5. Szodoray P,
    6. Zeher M
    . Functional and morphological evaluation of hand microcirculation with nailfold capillaroscopy and laser Doppler imaging in Raynaud’s and Sjögren’s syndrome and poly/dermatomyositis. Scand J Rheumatol 2008;37:23–9.
    OpenUrlCrossRefPubMed
  17. 17.↵
    1. Moore TL,
    2. Vij S,
    3. Murray AK,
    4. Bhushan M,
    5. Griffiths CE,
    6. Herrick AL
    . Pilot study of dual-wavelength (532 and 633 nm) laser Doppler imaging and infrared thermography of morphoea. Br J Dermatol 2009;160:864–7.
    OpenUrlCrossRefPubMed
  18. 18.↵
    1. Preliminary criteria for the classification of systemic sclerosis (scleroderma)
    . Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Arthritis Rheum 1980;23:581–90.
    OpenUrlCrossRefPubMed
  19. 19.↵
    1. Valentini G,
    2. Silman AJ,
    3. Veale D
    . Assessment of disease activity. Clin Exp Rehumatol 2003;21 Suppl:39–41.
    OpenUrl
  20. 20.↵
    1. Medsger TA, Jr,
    2. Bombardieri S,
    3. Czirjak L,
    4. Scorza R,
    5. Della Rossa A,
    6. Bencivelli W
    . Assessment of severity and prognosis. Clin Exp Rehumatol 2003;21 Suppl:42–6.
    OpenUrl
  21. 21.↵
    1. LeRoy EC,
    2. Medsger TA, Jr
    . Raynaud’s phenomenon: a proposal for classification. Clin Exp Rheumatol 1992;10:485–8.
    OpenUrlPubMed
  22. 22.↵
    1. Kellogg DL, Jr
    . In vivo mechanisms of cutaneous vasodilation and vasoconstriction in humans during thermoregulatory challenges. J Appl Physiol 2006;100:1709–18.
    OpenUrlAbstract/FREE Full Text
  23. 23.↵
    1. Yamane K
    . Endothelin and collagen vascular disease: a review with special reference to Raynaud’s phenomenon and systemic sclerosis. Intern Med 1994;33:579–82.
    OpenUrlPubMed
  24. 24.↵
    1. Herrick AL
    . Vascular function in systemic sclerosis. Curr Opin Rheumatol 2000;12:527–33.
    OpenUrlCrossRefPubMed
  25. 25.↵
    1. Kuryliszyn-Moskal A,
    2. Klimiuk PA,
    3. Sierakowski S
    . Soluble adhesion molecules (sVCAM-1, sE-selectin), vascular endothelial growth factor (VEGF) and endothelin-1 in patients with systemic sclerosis: relationship to organ systemic involvement. Clin Rheumatol 2005;24:111–6.
    OpenUrlCrossRefPubMed
  26. 26.↵
    1. Choi JJ,
    2. Min DJ,
    3. Cho ML,
    4. Min SY,
    5. Kim SJ,
    6. Lee SS,
    7. et al.
    Elevated vascular endothelial growth factor in systemic sclerosis. J Rheumatol 2003;30:1529–33.
    OpenUrlAbstract/FREE Full Text
  27. 27.↵
    1. Sato S,
    2. Hasegawa M,
    3. Takehara K
    . Serum levels of interleukin-6 and interleukin-10 correlate with total skin thickness score in patients with systemic sclerosis. J Dermatol Sci 2001;27:140–6.
    OpenUrlCrossRefPubMed
  28. 28.↵
    1. Kahaleh B,
    2. Matucci-Cerinic M
    . Raynaud’s phenomenon and scleroderma. Dysregulated neuroendothelial control of vascular tone. Arthritis Rheum 1995;38:1–14.
    OpenUrlCrossRefPubMed
  29. 29.↵
    1. Fagrell B
    . Advances in microcirculation network evaluation: an update. Int J Microcirc Clin Exp 1995;15 Suppl:34–40.
    OpenUrlCrossRefPubMed
  30. 30.↵
    1. Groner W,
    2. Winkelman JW,
    3. Harris AG,
    4. Ince C,
    5. Bouma GJ,
    6. Messmer K,
    7. et al.
    Orthogonal polarization spectral imaging: a new method for study of the microcirculation. Nat Med 1999;5:1209–12.
    OpenUrlCrossRefPubMed
  31. 31.↵
    1. Holloway GA, Jr,
    2. Watkins DW
    . Laser Doppler measurement of cutaneous blood flow. J Invest Dermatol 1977;69:306–9.
    OpenUrlCrossRefPubMed
  32. 32.↵
    1. Seifalian AM,
    2. Howell K,
    3. Stansby G,
    4. Jackson AE,
    5. Hamilton G,
    6. Black CM
    . Laser Doppler perfusion imaging: a new technique for measuring skin blood flow in rheumatology. Br J Rheumatol 1993;32:938.
    OpenUrlFREE Full Text
  33. 33.↵
    1. Murray AK,
    2. Herrick AL,
    3. King TA
    . Laser Doppler imaging: a developing technique for application in the rheumatic diseases. Rheumatology 2004;43:1210–8.
    OpenUrlFREE Full Text
Back to top

In this issue

Print
Download PDF
Article Alerts
Email Article
Citation Tools

 Request Permissions

Save to my folders

Jump to section